# Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement

> **NCT07487246** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Rush University Medical Center** · enrollment: 76 (estimated)

## Conditions studied

- Pain Management
- Abortion
- Second Trimester Abortion
- Dilation and Evacuation

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** oral ibuprofen
- **DRUG:** Placebo
- **DRUG:** Lidocaine HCl 1%
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT07487246
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07487246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07487246, "Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07487246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*